FAKTOR OPTIONSSCHEIN - AMGEN | Market Closed - Deutsche Boerse AG 13:32:53 2024-05-10 EDT | ||
| 1.01 EUR | +1.00% |
|
| Current month | -51.90% | ||
| 1 month | -57.92% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-10 | 1.01 | +1.00% | 0 |
| 24-05-09 | 1 | -11.50% | 0 |
| 24-05-08 | 1.13 | -5.83% | 0 |
| 24-05-07 | 1.2 | 0.00% | 0 |
| 24-05-06 | 1.2 | +25.00% | 0 |
Delayed Quote Deutsche Boerse AG
Last update May 10, 2024 at 01:32 pm
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | UBS |
| WKN | UL65UV |
| ISIN | DE000UL65UV7 |
| Date issued | 2023-08-01 |
| Strike | 391.1 $ |
| Maturity | Unlimited |
| Parity | 71.19 : 1 |
| Emission price | 5.63 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 6.48 € |
|---|---|
| Lowest since issue | 0.76 € |
| Spread | 0.03 € |
| Spread % | 2.83% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
310.2
USD
Average target price
314.6
USD
Spread / Average Target
+1.45%
- Stock Market
- Certificates
- Certificat